Expression of E-cadherin and other paracellular junction genes is decreased in iron-loaded hepatocytes

American Journal of Pathology

Volumn 162, Issue 4, 2003, Pages 1323-1338

  Bilello, John P ^a   Cable, Edward E ^a   Isom, Harriet C ^a,b  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; MESSENGER RNA; UVOMORULIN;

ANIMAL CELL; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; BLOOD TRANSFUSION; CELL COMMUNICATION; CELL JUNCTION; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENE TRANSFER; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOLOCALIZATION; IRON INTAKE; IRON OVERLOAD; IRON STORAGE; LIVER CELL; LIVER CIRRHOSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RAT; THALASSEMIA; VIRAL GENE DELIVERY SYSTEM;

EID: 0037378611     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63928-4     Document Type: Article

References (108)

1. Harford JB, Rouault TA, Huebers HA, Klausner RD: Molecular mechanisms of iron metabolism. The Molecular Basis of Blood Diseases. Edited by G Stamatoyannopoulos, AW Nienhuis, PW Majerus, H Varmus. Philadelphia, W. B. Saunders, 1994, pp 351-397
2. Philpott CC: Molecular aspects of iron absorption: insights into the role of HFE in hemochromatosis. Hepatology 2002, 35:993-1001
3. Levy JE, Montross LK, Andrews NC: Genes that modify the hemochromatosis phenotype in mice. J Clin Invest 2000, 105:1209-1216
4. Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnick MH, Kushner JP: Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988, 318:1355-1362
5. Prows CA: Hereditary hemochromatosis. Nur Clin N Am 2000, 35:707-717
6. Bonkovsky HL: Iron and the liver. Am J Med Sci 1991, 301:32-43
7. Bothwell TH, Charlton RW, Motulsky AG: Hemochromatosis. The Metabolic and Molecular Basis of Inherited Disease. Edited by CR Scriver, AL Beaudet, WS Sly, D Valle. New York, McGraw-Hill, 1995, pp 2237-2269
8. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo Jr R, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BEKGS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Prass CE, Quintana L, Starnes SM, Schatzman RC, Brunke KJ, Drayna DT, Risch NJ, Bacon BR, Wolff RK: A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996, 13:399-408
9. Deugnier YM, Loreal O, Turlin B, Guyader D, Jouanolle H, Moirand R, Jacquelinet C, Brissot P: Liver pathology in genetic hemochromatosis: a review of 135 homozygous cases and their bioclinical correlations. Gastroenterology 1992, 102:2050-2059
10. Gumbiner BM: Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996, 84:345-357
11. Wang G, Zabner J, Deering C, Launspach J, Shao J, Bodner M, Jolly DJ, Davidson BL, McCray Jr PB: Increasing epithelial junction permeability enhances gene transfer to airway epithelia in vivo. Am J Resp Cell Mol 2000, 22:129-138
12. Denker BM, Nigam SK: Molecular structure and assembly of the tight junction. Am J Physiol 1998, 274:F1-F9
13. Mitic LL, Anderson JM: Molecular architecture of tight junctions. Annu Rev Physiol 1998, 60:121-142
14. Yap AS, Brieher WM, Gumbiner BM: Molecular and functional analysis of cadherin-based adherens junctions. Annu Rev Cell Dev Biol 1997, 13:119-146
15. Birchmeier W, Behrens J: Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim Biophys Acta 1994, 1198:11-26
16. Isom HC, Secott T, Georgoff I, Woodworth C, Mummaw J: Maintenance of differentiated rat hepatocytes in primary culture. Proc Natl Acad Sci USA 1985, 82:3252-3256
17. Isom H, Georgoff I, Salditt-Georgieff M, Darnell Jr JE: Persistence of liver-specific messenger RNA in cultured hepatocytes: different regulatory events for different genes. J Cell Biol 1987, 105:2877-2885
18. Serra R, Isom HC: Stimulation of DNA synthesis and protooncogene expression in primary rat hepatocytes in long-term DMSO culture. J Cell Physiol 1993, 154:543-553
19. Cable EE, Isom HC: Metabolism of 3,5,5-trimethylhexanoyl-ferrocene by rat liver: release of iron from 3,5,5-trimethylhexanoyl-ferrocene by a microsomal, phenobarbital-inducible cytochrome P-450. Drug Metab Dispos 1999, 27:255-260
20. Cable EE, Connor JR, Isom HC: Accumulation of iron by primary rat hepatocytes in long-term culture: changes in nuclear shape mediated by non-transferrin-bound forms of iron. Am J Pathol 1998, 152:781-792
21. Hu JM, Camper SA, Tilghman SM, Miller T, Georgoff I, Serra R, Isom HC: Functional analyses of albumin expression in a series of hepatocyte cell lines and in primary hepatocytes. Cell Growth Differ 1992, 3:577-588
22. Cable EE, Isom HC: Exposure of primary rat hepatocytes in long-term DMSO culture to selected transition metals induces hepatocyte proliferation and formation of duct-like structures. Hepatology 1997, 26:1444-1457
23. Woodworth C, Secott T, Isom HC: Transformation of rat hepatocytes by transfection with simian virus 40 DNA to yield proliferating differentiated cells. Cancer Res 1986, 46:4018-4026
24. Woodworth CD, Isom HC: Transformation of differentiated rat hepatocytes with adenovirus and adenovirus DNA. J Virol 1987, 61:3570-3579
25. Woodworth CD, Isom HC: Regulation of albumin gene expression in a series of rat hepatocyte cell lines immortalized by simian virus 40 and maintained in chemically defined medium. Mol Cell Biol 1987, 7:3740-3748
26. Bour ES, Ward LK, Cornman GA, Isom HC: Tumor necrosis factor-alpha-induced apoptosis in hepatocytes in long-term culture. Am J Pathol 1996, 148:485-495
27. Cable EE, Miller TG, Isom HC: Regulation of heme metabolism in rat hepatocytes and hepatocyte cell lines: δ-aminolevulinic acid synthase and heme oxygenase are regulated by different heme-dependent mechanisms. Arch Biochem Biophys 2000, 384:280-295
28. Parkes JG, Randell EW, Olivieri NF, Templeton DM: Modulation by iron loading and chelation of the uptake of non-transferrin-bound iron by human liver cells. Biochim Biophys Acta 1995, 1243:373-380
29. Lescoat G, Loreal O, Moirand R, Dezier JF, Pasdeloup N, Deugnier Y, Brissot P: Iron induction of ferritin synthesis and secretion in human hepatoma cell (Hep G2) cultures. Liver 1989, 9:179-185
30. Goto Y, Paterson M, Listowsky I: Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free media. J Biol Chem 1983, 258:5248-5255
31. Dullmann J, Wulfhekel U, Nielsen P, Heinrich HC: Iron overload of the liver by trimethylhexanoylferrocene in rats. Acta Anat 1992, 143:96-108
32. Nielsen P, Heinelt S, Dullmann J: Chronic feeding of carbonyl-iron and TMH-ferrocene in rats. Comparison of two iron-overload models with different iron absorption. Comp Pharmacol Toxicol 1993, 106:429-436
33. Nielsen P, Heinrich HC: Metabolism of iron from (3,5,5-trimethylhexanoyl)ferrocene in rats. A dietary model for severe iron overload. Biochem Pharmacol 1993, 45:385-391
34. Delaney IV WE, Isom HC: Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 1998, 28:1134-1146
35. Maslak M, Martin CT: Kinetic analysis of T7 RNA polymerase transcription initiation from promoters containing single-stranded regions. Biochemistry 1993, 32:4281-4285
36. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159
37. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC: Measurement of protein using bicinchoninic acid. Anal Biochem 1985, 150:76-85
38. Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970, 227:680-685
39. El-Fouly MH, Trosko JE, Chang CC: Scrape-loading and dye transfer. A rapid and simple technique to study gap junctional intercellular communication. Exp Cell Res 1987, 168:422-430
40. Kojima T, Mitaka T, Mizuguchi T, Mochizuki Y: Effects of oxygen radical scavengers on connexins 32 and 26 expression in primary cultures of adult rat hepatocytes. Carcinogenesis 1996, 17:537-544
41. Bilello JP, Delaney IV WE, Boyce FM, Isom HC: Transient disruption of intercellular junctions enables baculovirus entry into nondividing hepatocytes. J Virol 2001, 75:9857-9871
42. Bilello JP, Cable EE, Myers RL, Isom HC: Role of paracellular junction complexes in baculovirus-mediated gene transfer to non-dividing rat hepatocytes. Gene Ther (in press)
43. Nusrat A, Parkos CA, Verkade P, Foley CS, Liang TW, Innis-Whitehouse W, Eastburn KK, Madara JL: Tight junctions are membrane microdomains. J Cell Sci 2000, 113:1771-1781
44. Persidsky MD, Baillie GS: Fluorometric test of cell membrane integrity. Cryobiology 1977, 14:322-331
45. Rotman B, Papermaster BW: Membrane properties of living mammalian cells as studied by enzymatic hydrolysis of fluorogenic esters. Proc Natl Acad Sci USA 1966, 55:134-141
46. Barth CA, Schwarz LR: Transcellular transport of fluorescein in hepatocyte monolayers: evidence for functional polarity of cells in culture. Proc Natl Acad Sci USA 1982, 79:4985-4987
47. Aeschbacher M, Reinhardt CA, Zbinden G: A rapid cell membrane permeability test using fluorescent dyes and flow cytometry. Cell Biol Toxicol 1986, 2:247-255
48. Prosperi E: Intracellular turnover of fluorescein diacetate. Influence on membrane ionic gradients on fluorescein efflux. Histochem J 1990, 22:227-233
49. De La Vega FM, Mendoza-Figueroa T: Dimethyl sulfoxide enhances lipid synthesis and secretion by long-term cultures of adult rat hepatocytes. Biochimie 1991, 73:621-624
50. Jeong TC, Jeong HG, Yang KH: Induction of cytochrome P-450 by dimethyl sulfoxide in primary cultures of adult rat hepatocytes. Toxicol Lett 1992, 61:275-281
51. Lindsay CK, Chenery RJ, Hawksworth GM: Primary culture of rat hepatocytes in the presence of dimethyl sulfoxide. A system to investigate the regulation of cytochrome P450 IA. Blochem Pharmacol 1991, 42:S17-S25
52. Muakkassah-Kelly SF, Bieri F, Waechter F, Bentley P, Staubli W: Long-term maintenance of hepatocytes in primary culture in the presence of DMSO: further characterization and effect of nafenopin, a peroxisome proliferator. Exp Cell Res 1987, 171:37-51
53. Muakkassah-Kelly SF, Bieri F, Waechter F, Bentley P, Staubli W: The use of primary cultures of adult rat hepatocytes to study induction of enzymes and DNA synthesis: effect of nafenopin and electroporation. Experientia 1988, 44:823-827
54. Villa P, Arioli P, Guaitani A: Mechanism of maintenance of liver-specific functions by DMSO in cultures rat hepatocytes. Exp Cell Res 1991, 194:157-160
55. Borrmann CM, Mertens C, Schmidt A, Langbein L, Kuhn C, Franke WW: Molecular diversity of plaques of epithelial-adhering junctions. Ann NY Acad Sci 2000, 915:144-150
56. Fujikura Y, Ohta H, Hirai T, Fukumoto T: Immunohistochemical analysis of rat liver using a monoclonal antibody (HAM8) against gap junction. Anat Rec 1993, 235:335-341
57. Fujimoto K: Freeze-fracture replica electron microscopy combined with SDS digestion for cytochemical labeling of integral membrane proteins. Application to the immunogold labeling of intercellular junctional complexes. J Cell Sci 1995, 108:3443-3449
58. Novikoff PM, Ikeda T, Hixson DC, Yam A: Characterizations of and interactions between bile ductule cells and hepatocytes in early stages of rat hepatocarcinogenesis induced by ethionine. Am J Pathol 1991, 139:1351-1368
59. Tateno C, Yoshizato K: Long-term cultivation of adult rat hepatocytes that undergo multiple cell divisions and express normal parenchymal phenotypes. Am J Pathol 1996, 148:383-392
60. Tsukita S, Tsukita S: Isolation of cell-to-cell adherens junctions from rat liver. J Cell Biol 1989, 108:31-41
61. Bazzoni G, Martinez-Estrada OM, Orsenigo F, Cordenonsi M, Citi S, Dejana E: Interaction of junctional adhesion molecule with the tight junction components Zo-1, cingulin, and occludin. J Biol Chem 2000, 275:20520-20526
62. Heymann R, Kallenbach S, Alonso S, Carroll P, Mitsiadis TA: Dynamic expression patterns of the new protocadherin families CNRs and Pcdh-gamma during mouse odontogenesis: comparison with reelin expression. Mech Dev 2001, 106:181-184
63. Suzuki ST: Recent progress in protocadherin research. Exp Cell Res 2000, 261:13-18
64. Wijnhoven BP, Dinjens WN, Pignatelli M: E-cadherin-catenin cell-cell adhesion complex and human cancer. Br J Surg 2000, 87:992-1005
65. Nishiyama M, Ozturk M, Frohlich M, Mafune K, Steele Jr G, Wands JR: Expression of human alpha-actinin in human hepatocellular carcinoma. Cancer Res 1990, 50:6291-6294
66. Nollet F, Berx G, van Roy F: The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Com 1999, 2:77-85
67. Park WS, Oh RR, Park JY, Kim PJ, Shin MS, Lee JH, Kim HS, Lee SH, Kim SY, Park YG, An WG, Kim HS, Jang JJ, Yoo NJ, Lee JY: Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol 2001, 193:483-490
68. Williams BO, Barish GD, Klymkowsky MW, Varmus HE: A comparative evaluation of beta-catenin and plakoglobin signaling activity. Oncogene 2000, 19:5720-5728
69. Tsukada N, Ackerley CA, Phillips MJ: The structure and organization of the bile canalicular cytoskeleton with special reference to actin and actin-binding proteins. Hepatology 1995, 21:1106-1113
70. Hiscox S, Jiang WG: Ezrin regulates cell-cell and cell-matrix adhesion, a possible role with E-cadherin/beta-catenin. J Cell Sci 1999, 112:3081-3090
71. Birchmeier W, Weidner KM, Behrens J: Molecular mechanisms leading to loss of differentiation and gain of invasiveness in epithelial cells. J Cell Sci 1993, 17:159-164
72. Birchmeier W, Weidner KM, Hulsken J, Behrens J: Molecular mechanisms leading to cell junction (cadherin) deficiency in invasive carcinomas. Semin Cancer Biol 1993, 4:231-239
73. Battle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000, 2:84-89
74. Haira KM, Ji X, Fearon ER: Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 1999, 18:7274-7279
75. Hennig G, Lowrick O, Birchmeier W, Behrens J: Mechanisms identified in the transcriptional control of epithelial gene expression. J Biol Chem 1996, 271:595-602
76. Hennig G, Behrens J, Truss M, Frisch S, Reichmann E, Birchmeier W: Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. Oncogene 1995, 11:475-484
77. Behrens J: Cadherins and catenins: role in signal transduction and tumor progression. Cancer Metastasis Rev 1999, 18:15-30
78. Ikeda S, Kishida S, Yamamoto H, Murai H, Koyama S, Kikuchi A: Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin. EMBO J 1998, 17:1371-1384
79. Fagotto F, Jho Eh, Zeng L, Kurth T, Joos T, Kaufmann C, Costantini F: Domains of axin involved in protein-protein interactions, Wnt pathway inhibition, and intracellular localization. J Cell Biol 1999, 145:741-756
80. Sakanaka C, Weiss JB, Williams LT: Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription. Proc Natl Acad Sci USA 1998, 95:3020-3023
81. Behrens J: Control of beta-catenin signaling in tumor development. Ann NY Acad Sci 2000, 910:21-33
82. Jeng YM, Wu MZ, Mao TL, Chang MH, Hsu HC: Somatic mutations of beta-catenin play a crucial role in the tumorigenesis of sporadic hepatoblastoma. Cancer Lett 2000, 152:45-51
83. Wagenaar RA, Crawford HC, Matrisian LM: Stabilized β-catenin immortalizes colonic epithelial cells. Cancer Res 2001, 61:2097-2104
84. Galbiati F, Volonte D, Brown AM, Weinstein DE, Ben-Ze'ev A, Pestell RG, Lisanti MP: Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains. J Biol Chem 2000, 275:23368-23377
85. Kumar NM, Gilula NB: The gap junction communication channel. Cell 1996, 84:381-388
86. Kontoghiorghes GJ, Weinberg ED: Iron: mammalian defense systems, mechanisms of disease, and chelation therapy approaches. Blood Rev 1995, 9:33-45
87. Weinberg ED: Iron depletion: a defense against intracellular infection and neoplasia. Life Sci 1992, 50:1289-1297
88. Weinberg ED: Iron in neoplastic disease. Nutr Cancer 1983, 4:223-233
89. Weinberg ED: Iron loading and disease surveillance. Emerg Infect Dis 1999, 5:346-352
90. Weinberg ED: Iron withholding: a defense against infection and neoplasia. Physiol Rev 1984, 64:65-102
91. Weinberg ED: Roles of iron in infection and neoplasia. J Pharmacol Paris 1985, 16:358-364
92. Weinberg ED: Roles of iron in neoplasia. Promotion, prevention, and therapy. Biol Trace Elem Res 1992, 34:123-140
93. Reizenstein P: Iron, free radicals and cancer. Med Oncol Tumor Pharmacol 1991, 8:229-233
94. Engelhardt R, Langkowski JH, Fischer R, Nielsen P, Kooijman H, Keinrich HC, Bucheler E: Liver iron quantification: studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magn Reson Imaging 1994, 12:999-1007
95. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trampisch HJ, Strohmeyer G: Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985, 313:1256-1262
96. Bomford A, Williams R: Long term results of venesection therapy in idiopathic haemochromatosis. Q J Med 1976, 45:611-623
97. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, Bianchi PA, Fiorelli G, Conte D: Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 1992, 15:655-659
98. Tiniakos G, Williams R: Cirrhotic process, liver cell carcinoma and extrahepatic malignant tumors in idiopathic haemochromatosis. Study of 71 patients treated with venesection therapy. Appl Pathol 1988, 6:128-138
99. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, Portillo F, Nieto MA: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000, 2:76-83
100. Huang GT, Lee HS, Chen CH, Sheu JC, Chiou LL, Chen DS: Correlation of E-cadherin expression and recurrence of hepatocellular carcinoma. Hepatogastroenterology 1999, 46:1923-1927
101. Nuruki K, Toyoyama H, Ueno S, Hamanoue M, Tanabe G, Aikou T, Ozawa M: E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas. Oncol Rep 1998, 5:1109-1114
102. Endo K, Ueda T, Ueyama J, Ohta T, Terada T: Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol 2000, 31:558-565
103. Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK: Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology 2001, 33:1098-1109
104. Ashida K, Terada T, Kitamura Y, Kaibara N: Expression of E-cadherin, alpha-catenin, beta-catenin, and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology 1998, 27:974-982
105. Ihara A, Koizumi H, Hashizume R, Uchikoshi T: Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 1996, 23:1441-1447
106. Ikeguchi M, Makino M, Kaibara N: Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma. J Surg Oncol 2001, 77:201-207
107. Krishnadath KK, Tilanus HW, van Blankenstein M, Hop WC, Kremers ED, Dinjens WN, Bosman FT: Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 1997, 182:331-338
108. Hao X, Palazzo JP, Ilyas M, Tomlinson I, Talbot IC: Reduced expression of molecules of the cadherin/catenin complex in the transition from colorectal adenoma to carcinoma. Anticancer Res 1997, 17:2241-2247